About the Work
The Initiative for Medicines, Access, & Knowledge (I-MAK) is a team of attorneys, scientists, and health experts whose mission is to build a more just and equitable medicines system for all.
In close cooperation with their team, I designed the report for their 2022 study on how patent abuse in the U.S. is impacting the 10 top selling drugs in the country. You can read the full report here.
Senator Peter Welch (D-VT) using a chart from the report to demonstrate how AbbVie’s extended patent protection allowed it to hike up the price of the drug Humira.
